These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

306 related items for PubMed ID: 16061391

  • 1. Comparative activity of Sant7 and anti-IL-6, IL-6R monoclonal antibodies in a murine model of B-cell lymphoma.
    Campo S, Serlupi-Crescenzi O, Arseni B, Rossi S, Saggio I, Salone B, Cherubini G, Carminati P, De Santis R.
    Cytokine; 2005 Sep 07; 31(5):368-74. PubMed ID: 16061391
    [Abstract] [Full Text] [Related]

  • 2. Combination therapy with interleukin-6 receptor superantagonist Sant7 and dexamethasone induces antitumor effects in a novel SCID-hu In vivo model of human multiple myeloma.
    Tassone P, Neri P, Burger R, Savino R, Shammas M, Catley L, Podar K, Chauhan D, Masciari S, Gozzini A, Tagliaferri P, Venuta S, Munshi NC, Anderson KC.
    Clin Cancer Res; 2005 Jun 01; 11(11):4251-8. PubMed ID: 15930364
    [Abstract] [Full Text] [Related]

  • 3. Pathogenic role of interleukin-6 in the development of sepsis. Part II: Significance of anti-interleukin-6 and anti-soluble interleukin-6 receptor-alpha antibodies in a standardized murine contact burn model.
    Pallua N, Low JF, von Heimburg D.
    Crit Care Med; 2003 May 01; 31(5):1495-501. PubMed ID: 12771624
    [Abstract] [Full Text] [Related]

  • 4. Human interleukin-6 is in vivo an autocrine growth factor for human herpesvirus-8-infected malignant B lymphocytes.
    Foussat A, Wijdenes J, Bouchet L, Gaidano G, Neipel F, Balabanian K, Galanaud P, Couderc J, Emilie D.
    Eur Cytokine Netw; 1999 Dec 01; 10(4):501-8. PubMed ID: 10586116
    [Abstract] [Full Text] [Related]

  • 5. Local blockade of IL-6R signaling induces lung CD4+ T cell apoptosis in a murine model of asthma via regulatory T cells.
    Finotto S, Eigenbrod T, Karwot R, Boross I, Doganci A, Ito H, Nishimoto N, Yoshizaki K, Kishimoto T, Rose-John S, Galle PR, Neurath MF.
    Int Immunol; 2007 Jun 01; 19(6):685-93. PubMed ID: 17496315
    [Abstract] [Full Text] [Related]

  • 6. Viral Interleukin-6: Structure, pathophysiology and strategies of neutralization.
    Suthaus J, Adam N, Grötzinger J, Scheller J, Rose-John S.
    Eur J Cell Biol; 2011 Jun 01; 90(6-7):495-504. PubMed ID: 21176991
    [Abstract] [Full Text] [Related]

  • 7. Sensitization of human renal cell carcinoma cells to cis-diamminedichloroplatinum(II) by anti-interleukin 6 monoclonal antibody or anti-interleukin 6 receptor monoclonal antibody.
    Mizutani Y, Bonavida B, Koishihara Y, Akamatsu K, Ohsugi Y, Yoshida O.
    Cancer Res; 1995 Feb 01; 55(3):590-6. PubMed ID: 7834629
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Development of a monoclonal antibody-based enzyme-linked immunoabsorbent assay for the binding of gp130 to the IL-6/IL-6R complex and its competitive inhibition.
    Scheller J, Kovaleva M, Rabe B, Eichler J, Kallen KJ, Rose-John S.
    J Immunol Methods; 2004 Aug 01; 291(1-2):93-100. PubMed ID: 15345308
    [Abstract] [Full Text] [Related]

  • 10. Anti-CD45 and anti-CD52 (Campath) monoclonal antibodies effectively eliminate systematically disseminated human non-Hodgkin's lymphoma B cells in Scid mice.
    de Kroon JF, de Paus RA, Kluin-Nelemans HC, Kluin PM, van Bergen CA, Munro AJ, Hale G, Willemze R, Falkenburg JH.
    Exp Hematol; 1996 Jul 01; 24(8):919-26. PubMed ID: 8690051
    [Abstract] [Full Text] [Related]

  • 11. Soluble interleukin 6 receptor is biologically active in vivo.
    Mackiewicz A, Wiznerowicz M, Roeb E, Karczewska A, Nowak J, Heinrich PC, Rose-John S.
    Cytokine; 1995 Feb 01; 7(2):142-9. PubMed ID: 7780033
    [Abstract] [Full Text] [Related]

  • 12. Optimizing therapeutic strategies to inhibit circulating soluble target molecules with monoclonal antibodies: example of the soluble IL-6 receptors.
    Brochier J, Liautard J, Jacquet C, Gaillard JP, Klein B.
    Eur J Immunol; 2001 Jan 01; 31(1):259-64. PubMed ID: 11265642
    [Abstract] [Full Text] [Related]

  • 13. Establishment of the ELISA for murine soluble gp130, a signal transducer for the IL-6 family cytokine, and its detection in the ascitic fluids of tumor-bearing mice.
    Matsuda T, Hirano T.
    Biochem Biophys Res Commun; 1994 Jul 15; 202(1):637-42. PubMed ID: 8037770
    [Abstract] [Full Text] [Related]

  • 14. Anti-human interleukin-6 receptor antibody inhibits human myeloma growth in vivo.
    Suzuki H, Yasukawa K, Saito T, Goitsuka R, Hasegawa A, Ohsugi Y, Taga T, Kishimoto T.
    Eur J Immunol; 1992 Aug 15; 22(8):1989-93. PubMed ID: 1639101
    [Abstract] [Full Text] [Related]

  • 15. Treatment of rheumatoid synovitis with anti-reshaping human interleukin-6 receptor monoclonal antibody: use of rheumatoid arthritis tissue implants in the SCID mouse model.
    Matsuno H, Sawai T, Nezuka T, Uzuki M, Tsuji H, Nishimoto N, Yoshizaki K.
    Arthritis Rheum; 1998 Nov 15; 41(11):2014-21. PubMed ID: 9811057
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Murine anti-human IL-6 monoclonal antibody prolongs the half-life in circulating blood and thus prolongs the bioactivity of human IL-6 in mice.
    Mihara M, Koishihara Y, Fukui H, Yasukawa K, Ohsugi Y.
    Immunology; 1991 Sep 15; 74(1):55-9. PubMed ID: 1718855
    [Abstract] [Full Text] [Related]

  • 19. Therapeutic potential of humanized anti-interleukin-6 receptor antibody: antitumor activity in xenograft model of multiple myeloma.
    Tsunenari T, Akamatsu K, Kaiho S, Sato K, Tsuchiya M, Koishihara Y, Kishimoto T, Ohsugi Y.
    Anticancer Res; 1996 Sep 15; 16(5A):2537-44. PubMed ID: 8917348
    [Abstract] [Full Text] [Related]

  • 20. [Novel vaccines against M. tuberculosis].
    Okada M.
    Kekkaku; 2006 Dec 15; 81(12):745-51. PubMed ID: 17240920
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.